Supply Chain

Software issues continued to drive medical device recalls during the third quarter of 2018, reflecting the growing popularity of internet-connected products, according to a recent analysis of U.S. recall data.

The Red Cross announced Nov. 13 it received 21,000 fewer blood donations in the months of September and October than it needed.

The FDA's policies and procedures don't sufficiently outline how to respond to cybersecurity risks for medical devices in the postmarket phase, according to a report from the HHS Office of Inspector General.

Some smartphones from Samsung Electronics may soon offer users with diabetes access to an insulin pump delivery system, thanks to a collaboration with insulin pump manufacturer Insulet Corp.

Here are five drugs or medical devices that have been approved by the FDA since Nov. 2:

The U.S. Department of Homeland Security issued a vulnerability warning for certain Roche point of care handheld medical devices, according to FDA News.

As the supply shortage of GlaxoSmithKline's shingles vaccine continues, the drugmaker is making plans to ramp up production at a quicker pace, according to Bio Process International.

Reducing supply chain waste is a top priority for hospitals and health systems today, as the shift toward value-based care drives new cost saving initiatives.

Here are four drugs or medical devices that have been approved by the FDA since Oct. 26:

The FDA authorized 23andMe to market its pharmacogenetic report Oct. 31, marking the agency's first time greenlighting a direct-to-consumer DNA test for this purpose.